These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36525255)

  • 21. Vertical restraints among hospitals, physicians and health insurers that raise rivals' costs. A case study of Reazin v. Blue Cross and Blue Shield of Kansas, Inc. and Ocean State Physicians Health Plan, Inc. v. Blue Cross and Blue Shield of Rhode Island.
    Baker JB
    Am J Law Med; 1988; 14(2-3):147-69. PubMed ID: 3245541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitrust implications of health planning: National Gerimedical Hospital and Gerontology Center v. Blue Cross of Kansas City.
    Chase JB
    Am J Law Med; 1982; 8(3):321-48. PubMed ID: 7168454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ore. hospital appeals dismissal of lawsuit.
    Burda D
    Mod Healthc; 1992 Sep; 22(39):63. PubMed ID: 10120611
    [No Abstract]   [Full Text] [Related]  

  • 24. The response of the dominant firm to competition: the Ocean State case.
    Goldberg LG; Greenberg W
    Health Care Manage Rev; 1995; 20(1):65-74. PubMed ID: 7744607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Court decisions give Blues plans one win, one loss in separate antitrust cases.
    Halper HR; Kazon PM
    Bus Health; 1987 Mar; 4(5):51-2. PubMed ID: 10280673
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost containment in the health care field and the antitrust laws.
    Shapiro DI
    Am J Law Med; 1982; 7(4):425-35. PubMed ID: 7102679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of pharmacy benefit manager medication formularies in an electronic health record system and the Epocrates mobile application.
    Andrus MR; Forrester JB; Germain KE; Eiland LS
    J Manag Care Spec Pharm; 2015 Apr; 21(4):281-6. PubMed ID: 25803761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost questions. How antitrust, uniformity and exercise play their roles.
    McLaughlin N
    Mod Healthc; 2010 Oct; 40(43):20. PubMed ID: 21053445
    [No Abstract]   [Full Text] [Related]  

  • 29. Does health insurance coverage fall when nonprofit insurers become for-profits?
    Lieber EMJ
    J Health Econ; 2018 Jan; 57():75-88. PubMed ID: 29182936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pa.: keep 'em separated. Blues merger rejection could have wider implications.
    Vesely R
    Mod Healthc; 2009 Jan; 39(4):10. PubMed ID: 19213127
    [No Abstract]   [Full Text] [Related]  

  • 31. Formulary submission guidelines for Blue Cross and Blue Shield of Colorado and Nevada. Structure, application and manufacturer responsibilities.
    Langley PC
    Pharmacoeconomics; 1999 Sep; 16(3):211-24. PubMed ID: 10558036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitrust, competition, and health care reform.
    Bloch RE; Falk DM
    Health Aff (Millwood); 1994; 13(1):206-23. PubMed ID: 8188136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of care for mental disorders under the Blue Cross and Blue Shield plan for Federal employees, 1972.
    Reed LS
    Am J Psychiatry; 1974 Sep; 131(9):964-75. PubMed ID: 4416830
    [No Abstract]   [Full Text] [Related]  

  • 34. Health Care Efficiencies: Consolidation and Alternative Models vs. Health Care and Antitrust Regulation - Irreconcilable Differences?
    King MW
    Am J Law Med; 2017 Nov; 43(4):426-467. PubMed ID: 29452560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of provider control of Blue Shield plans on health care markets.
    Arnould RJ; DeBrock LM
    Econ Inq; 1985 Jul; 23(3):449-74. PubMed ID: 10274976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitrust charges fail to slow PPA action by insurer.
    Burda D
    Hospitals; 1986 Apr; 60(8):68-70. PubMed ID: 3754236
    [No Abstract]   [Full Text] [Related]  

  • 37. BCBS mutuals like flexibility.
    Shahoda T
    Hospitals; 1987 Apr; 61(7):33-4. PubMed ID: 3557365
    [No Abstract]   [Full Text] [Related]  

  • 38. Antitrust action averted. Agreement with Pa. attorney general allows UPMC merger to proceed.
    Becker C
    Mod Healthc; 2001 Oct; 31(44):14-5. PubMed ID: 11715731
    [No Abstract]   [Full Text] [Related]  

  • 39. Competition between non-profit and for-profit health insurers.
    Adamache KW; Sloan FA
    J Health Econ; 1983 Dec; 2(3):225-43. PubMed ID: 10264797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Making claims. A hospital that's still in the insurance business has drawn the ire of a private rival, with the legality of hidden payments at issue.
    Taylor M
    Mod Healthc; 2005 Jun; 35(25):6-7, 1. PubMed ID: 16004137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.